About Nova Leah
Nova Leah is a world leader in the provision of cybersecurity risk management solutions for medical device manufacturers and healthcare providers. Nova Leah’s flagship product, SelectEvidence™, is a cybersecurity risk management solution for connected medical devices that automates the continuous monitoring of vulnerabilities and the identification of related mitigations.
With SelectEvidence™, Nova Leah provides medical device manufacturers with an intelligent, automated and traceable approach to cybersecurity risk management. In September 2023, Nova Leah launches, SelectEvaluate®, which is transforming medical device third party risk management and continuous cybersecurity monitoring across the healthcare cybersecurity supply chain.
Nova Leah was founded by Dr. Anita Finnegan, government advisor and award-winning international expert in cybersecurity risk management. Finnegan is a published author and project leader of multiple, internationally regulated, industry standards for medical equipment in healthcare technology. Nova Leah is headquartered in Dundalk, Ireland with a US office in Boston.
Technology Ireland Awards | Ibec
Emerging Company of the Year -2019
High Potential Exporter Award
Export Industry Awards Winner 2019
KTI Impact Awards 2019
Spin-out Company Award Winner 2019
Of the World's Biggest Medical Device Firms
National and International Awards
International Standards and Regulations
Expert Technologists Employed
Dr. Anita Finnegan
Dr. Anita Finnegan founded Nova Leah in 2015 following the output of her doctoral research into cybersecurity risk management. Finnegan subsequently commercialised this into an award-winning framework for increased security and safety for connected medical devices. She is an advisor at government level on key issues around medical device security and has authored a number of critical papers for international bodies.
Finnegan has won numerous awards and has been recognised internationally as a leader in her field. She has been nominated twice for the EU prize for Women Innovators, which recognises the most talented women entrepreneurs in Europe and beyond. Nova Leah now employs over 30 cybersecurity specialists across our European headquarters in Dundalk, Ireland and our US operations in Boston. Our people are united in our vision to make the connected world safer for everyone.
Careers at Nova Leah
Our highly-skilled and ambitious team is making a real difference to the world of connected medical devices. We help manufacturers around the world to build safer, more secure products. As a part of the Nova Leah team, you are directly impacting and protecting the lives of millions of people. We employ and work with some of the industry’s most highly-respected professionals. Please visit our careers page to review our current vacancies.
About the Team
Nova Leah was founded in 2015 to increase the safety and security of connected medical devices. It employs a team of over 30 technology and cybersecurity specialists in Ireland and the US.
Dr. Fergal McCaffery
CO-FOUNDER & Head of Engineering
Dr. Anita Finnegan
FOUNDER & CEO
Peter Finnegan
CO-FOUNDER
Board of Directors
As well as our three founders, Nova Leah is supported by a vastly experienced board and international advisory board.
Barry Downes
Managing Partner at Sure Valley Ventures,
Board member (observer)
Denise Sidhu
Director and Partner at Kernel capital,
BoARD MEMBER
Milind Parate
Managing Director, Ventures at NOrthwell holdings
BOARD MEMBER
Life in Dundalk, Ireland
Nova Leah is based in Dundalk, Ireland, in a part of the country known as the ‘Ancient East’. Dundalk is located halfway between the two cities of Belfast and Dublin, and steeped in history, art and culture. The town itself lays claim to popular festivals, museums, galleries, historic houses and gardens. The surrounding county has a protected and unspoiled coastline, with magnificent beaches and ocean drives. It’s no wonder we have attracted some of the industry’s top talent to our state-of-the-art offices!
